Kayentis and RWS partner to improve clinical trial data confidence
MHRA expands its pioneering AI Airlock programme with £3.6m funding boost
Ardena opens new US bioanalytical laboratory
Gesynta Pharma doses first patient in endometriosis phase 2 trial
Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says